Celcuity
MN - MinneapolisDiagnostics
Focus: Celcuity is an oncology-focused diagnostics company specializing in PI3K/mTOR companion diagnostics and targeted therapies, primarily operating in breast cancer and prostate cancer segments.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Celcuity
AI assessmentNot HiringNo open roles listed right now. Follow Celcuity to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Gedatolisib
Breast Neoplasm Malignant FemaleClinical Trials (1)
NCT05134922Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009
N/AHelp build intelligence for Celcuity
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.